[Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment].
The author characterizes the edema as an important quantitative objective measure of severity for chronic venous diseases in both early and advanced stages. The problems of edema assessment methods and the importance of its management in clinical practice are discussed. The results of studies on the use of micronized purified flavonoid fraction (MPFF, Detralex) for edema syndrome coping are presented.
Sapelkin
S V
SV
D002908:Chronic Disease; D004145:Diosmin / Q000627:therapeutic use*; D004338:Drug Combinations; D004487:Edema / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006569:Hesperidin / Q000627:therapeutic use*; D006801:Humans; D011379:Prognosis; D012720:Severity of Illness Index; D014689:Venous Insufficiency / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D004338:Drug Combinations; C080675:S 5682; D004145:Diosmin; D006569:Hesperidin